Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Front Endocrinol (Lausanne). 2021 Apr 29;12:606964. doi: 10.3389/fendo.2021.606964. eCollection 2021.
Defects in the insulin receptor () gene cause various severe insulin resistance conditions, including Donohue syndrome (DS), Rabson-Mendenhall syndrome (RMS) and type A insulin resistance (type A-IR). This study aimed to investigate the clinical characterization and molecular defects in three Chinese children with -related insulin resistance syndrome.
We reviewed the clinical data of three Chinese children with -related insulin resistance syndrome from two unrelated kindreds. Genetic analysis was performed using whole-exome sequencing and the effects of the novel variants were further assessed by functional assays.
The proband with type A-IR presented with acanthosis nigricans, hypertrichosis, and euglycemia with mild insulin resistance in early childhood. His sister presented with features typical of type A-IR and was diagnosed with diabetes mellitus with severe insulin resistance at the age of 9.8 years. The proband with DS showed typical dysmorphic characteristics, severe intrauterine growth retardation, extreme insulin resistance, fasting hypoglycemia and postprandial hyperglycemia from birth. The heterozygote variants c.[3670G>A]; c.[3614C>T] were identified in both siblings with type A-IR; and c.[749_751del]; c.[3355C>T] in the patient with DS. studies showed that the novel variant c.749_751del [p.(Thr250del)] in the α-subunit, reduced expression of the mature INSR protein and severely impaired INSR function. In contrast, the novel variant c.3670G>A [p.(Val1224Met)] in the β-subunit had no effect on total protein expression and phosphorylation of INSR and Akt, suggesting that the variant p.Val1224Met appeared to be tolerated and was not responsible for the severe insulin resistance.
Our study detailed the clinical features of three patients with type A-IR and DS, and identified two novel variants in the gene. Functional assays indicated the novel variant p.Thr250del was pathogenic. In contrast, the novel variant p.Val1224Met was suggested to be tolerated by our experimental data, even though bioinformatics analyses predicted the variant as deleterious.
胰岛素受体()基因缺陷可导致多种严重的胰岛素抵抗疾病,包括唐纳霍伊综合征(DS)、雷布森-门登霍尔综合征(RMS)和 A 型胰岛素抵抗(A-IR)。本研究旨在探讨 3 例中国胰岛素抵抗综合征患儿的临床特征及分子缺陷。
我们回顾了来自 2 个无关家系的 3 例中国胰岛素抵抗综合征患儿的临床资料。采用全外显子组测序进行基因分析,并通过功能测定进一步评估新变异的影响。
A-IR 先证者在幼儿期表现为黑棘皮病、多毛症和糖耐量正常伴轻度胰岛素抵抗。其妹妹表现出典型的 A-IR 特征,9.8 岁时被诊断为糖尿病伴严重胰岛素抵抗。DS 先证者表现出典型的畸形特征、严重宫内生长迟缓、出生时即存在极度胰岛素抵抗、空腹低血糖和餐后高血糖。在 2 例 A-IR 患者中均发现杂合变异 c.[3670G>A]; c.[3614C>T];而在 DS 患者中发现 c.[749_751del]; c.[3355C>T]。功能研究表明,α亚单位中的新型变异 c.749_751del [p.(Thr250del)]导致成熟 INSR 蛋白表达减少和 INSR 功能严重受损。相比之下,β亚单位中的新型变异 c.3670G>A [p.(Val1224Met)]对 INSR 和 Akt 的总蛋白表达和磷酸化无影响,提示变异 p.Val1224Met 似乎是耐受的,与严重胰岛素抵抗无关。
本研究详细描述了 3 例 A-IR 和 DS 患者的临床特征,并在 基因中发现了 2 个新的变异。功能测定表明新型变异 p.Thr250del 是致病性的。相比之下,尽管生物信息学分析预测该变异有害,但我们的实验数据表明新型变异 p.Val1224Met 是耐受的。